{"nctId":"NCT01596283","briefTitle":"Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection","startDateStruct":{"date":"2012-04"},"conditions":["Liver Cancer"],"count":135,"armGroups":[{"label":"Standard fluid management","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Standard fluid management"]},{"label":"Goal directed fluid therapy","type":"ACTIVE_COMPARATOR","interventionNames":["Device: Goal directed fluid therapy with the Edwards EV1000 system"]}],"interventions":[{"name":"Standard fluid management","otherNames":[]},{"name":"Goal directed fluid therapy with the Edwards EV1000 system","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adults (18 years old or greater) who are able to provide informed consent.\n* Patients who undergo an open, elective liver resection. Including those initially approached laparoscopically but converted to an open resection and those undergoing additional procedures.\n\nExclusion Criteria:\n\n* Active coronary disease.\n* Patients with a history of coronary disease will be eligible if they have had a cardiac stress study showing no reversible ischemia and normal LV function within 3 months of operation.\n* Active symptomatic cerebrovascular disease.\n* Active congestive heart failure and ejection fraction \\<35%.\n* Active severe restrictive or obstructive pulmonary disease and resting SpO2 \\<90%.\n* Active renal dysfunction (Cr \\>1.8)\n* Abnormal coagulation parameters (INR \\> 1.8 not on Coumadin, or platelet count \\< 100,000 per mcL)\n* Presence of active infection including HIV\n* Patients with active atrial fibrillation or flutter.\n* Preoperative hypoalbuminemia (Albumin \\< 2g/dl).\n* Female patients who are pregnant (female patients of child-bearing potential must have a negative serum pregnancy test â‰¤ 14 days prior to surgery or 15 to 30 days prior to surgery with a negative urine pregnancy test the morning of surgery).\n* Presence of ascites.\n* BMI \\> 45 or \\<17","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Postoperative Complications","description":"The incidence of overall 30-day postoperative complications will be recorded. These are defined in the MSKCC Adverse Events Program and organized by categories reflecting organ systems and further subdivided into specific complications within those and graded.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"45","spread":null}]},{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"24","spread":null}]}]}]},{"type":"SECONDARY","title":"Low Cardiac Output Time","description":"Assess the impact of GDT compared to standard fluid therapy on the total time patients experience low cardiac output perioperatively","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":"113"},{"groupId":"OG001","value":"12","spread":"48"}]}]}]},{"type":"SECONDARY","title":"Total Volume of Fluid Used Perioperatively","description":"Assess the impact of GDT compared to standard fluid therapy on the total volume of fluid given intraoperatively","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":"1.1"},{"groupId":"OG001","value":"2.9","spread":"1.0"}]}]}]},{"type":"SECONDARY","title":"Total Volume of Fluid Used Postoperatively","description":"Postoperative fluid volume","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"0.6"},{"groupId":"OG001","value":"1.0","spread":"0.5"}]}]}]},{"type":"SECONDARY","title":"Postoperative Length of Stay","description":"Assess the impact of GDT compared to standard fluid therapy on net fluid balance for the total admission time","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":23,"n":66},"commonTop":["Alanine aminotransferase increased","Aspartate aminotransferase increased","Hyperglycemia","Hypoalbuminemia","Intra-abdominal infection of abscess"]}}}